Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diankuang Mengxing Decoction is a traditional Chinese medicine (TCM) herbal formula used as an adjunctive therapy in the treatment of schizophrenia and related psychiatric disorders. The decoction is typically combined with antipsychotic medications such as olanzapine to improve overall prognosis, alleviate symptoms, and reduce adverse effects associated with standard pharmacotherapy. Clinical studies suggest that this combination can enhance symptom relief and patient outcomes over antipsychotics alone. The precise mechanism of action is not fully elucidated but likely involves modulation of neurotransmitter systems and holistic regulation according to TCM principles[1][2][9]. The formula's composition may vary by practitioner or region; however, it is rooted in classical TCM approaches for treating mania ("diankuang") syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Diankuang Mengxing Decoction.